<SEC-DOCUMENT>0001654954-20-014016-index.html : 20201230 <SEC-HEADER>0001654954-20-014016.hdr.sgml : 20201230 <ACCEPTANCE-DATETIME>20201230152107 ACCESSION NUMBER: 0001654954-20-014016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20201224 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201230 DATE AS OF CHANGE: 20201230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMARILLO BIOSCIENCES INC CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20791 FILM NUMBER: 201425692 BUSINESS ADDRESS: STREET 1: AMARILLO BIOSCIENCES INC STREET 2: 4134 BUSINESS PARK DRIVE CITY: AMARILLO STATE: TX ZIP: 79110-4225 BUSINESS PHONE: (806) 376-1741 MAIL ADDRESS: STREET 1: AMARILLO BIOSCIENCES INC STREET 2: 4134 BUSINESS PARK DRIVE CITY: AMARILLO STATE: TX ZIP: 79110-4225 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>amar_8k.htm <DESCRIPTION>CURRENT REPORT <TEXT> Document 1 - file: amar_8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>amar_ex2-1.htm <DESCRIPTION>SECURITIES PURCHASE AGREEMENT DATED AS OF DECEMBER 24, 2020 <TEXT> Document 2 - file: amar_ex2-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>amar_ex99-1.htm <DESCRIPTION>PRESS RELEASE <TEXT> Document 3 - file: amar_ex99-1.htm
</DOCUMENT> </SEC-DOCUMENT>